Back to Results
First PageMeta Content
Health / CVS Pharmacy / Caremark Rx / Pharmacy / Compliance / Clinical trial / CVS Caremark / Pharmaceutical sciences / Pharmacology / Medicine


14-CVS-271 Hep C Letter_v2.indd
Add to Reading List

Document Date: 2014-09-16 13:37:01

Open Document

File Size: 577,04 KB

Share Result on Facebook

Company

Hepatitis C / CVS / CVS/caremark / Sovaldi / /

Country

United States / /

Currency

USD / /

Event

Person Communication and Meetings / /

Facility

PHARMACY CHANNEL CVS / /

IndustryTerm

treatment of Hepatitis C / other Hepatitis C therapies / Hepatitis C therapies / treatment for those who have more advanced disease / treatment for Hepatitis C / pharmaceutical / retail / /

MedicalCondition

Hepatitis C-caused / disease / Hepatitis C / /

MedicalTreatment

home infusion therapy / counseling / /

Organization

Food and Drug Administration / /

Person

Troyen A. Brennan / William Shrank / Alan Lotvin / /

Position

Chief Scientific Officer / driver / Executive Vice President / Chief Medical Officer / /

Product

M14 / ribavirin / /

SocialTag